CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis
|
|
- Terence Lewis Sullivan
- 7 years ago
- Views:
Transcription
1 CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis Grant Baldwin, PhD, MPH February 2, 2016 National Center for Injury Prevention and Control Division of Unintentional Injury Prevention
2 2002 Rapid Increase in Drug Overdose Death Rates by County SOURCE: NCHS Data Visualization Gallery
3 2007 Rapid Increase in Drug Overdose Death Rates by County SOURCE: NCHS Data Visualization Gallery
4 2014 Rapid Increase in Drug Overdose Death Rates by County SOURCE: NCHS Data Visualization Gallery
5 Deaths per 100,000 population Rise in Rx overdose deaths since 2000 and recent increase in heroin & fentanyl deaths 5 4 Commonly Prescribed Opioids like oxycodone or hydrocodone 3 Heroin 2 Methadone 1 0 Synthetic opioids like fentanyl SOURCE: National Vital Statistics System Mortality File.
6 Quarter billion opioid prescriptions in 2012
7 HHS Secretary s Opioid Initiative Focus on three priority areas that tackle the opioid crisis and significantly impact those struggling with substance use disorders to help save lives 1 Providing training and educational resources to assist health professionals in making informed prescribing decisions 2 Increasing use of Naloxone 3 Expanding the use of Medication-Assisted Treatment
8 Three Pillars of CDC s Work Improve data quality and track trends Strengthen state efforts by scaling up effective public health interventions Supply healthcare providers with resources to improve patient safety
9 Improving the quality & timeliness of opioid overdose surveillance WHAT WE RE DOING Generate near real-time surveillance of emergency department visits related to drug overdoses Improve surveillance of EMS transports related to drug overdoses WHY WE RE DOING IT An early warning of large increases or decreases of drug overdoses to better target prevention efforts Better understand changing demographic patterns of drug overdoses
10 Prevention for States (PfS) Provides states guidance and resources to prevent prescription drug overdoses by addressing problematic opioid prescribing Builds on the success of the Prevention Boost Funding Opportunity 16 states funded with average award ranging from $750K to $1M Funding to states with high burden and readiness to act Focus on high impact, data driven activities and give states flexibility to tailor their work
11 LOGIC MODEL Prescription Drug Overdose: Prevention for States and Prevention Boost* Targeting High-Risk Prescribers and High-Risk Patients** Inputs Funding Surveillance expertise TA on policy & program development Evaluation guidance Dissemination of best practices Outputs/Strategies*** Enhance and Maximize PDMPs Expand or improve proactive PDMP reporting Expand/maximize PDMPs as a surveillance system Implement mandatory PDMP registration or use Reduce PDMP data collection interval Evaluate existing PDMP practices* Improve Insurer/Health System Mechanisms Enhance Patient Review and Restriction (PRR) capacity Enhance other health insurer/system practices* Develop and apply metrics for inappropriate prescribing Identify high-risk groups among the insured Conduct cost analyses Identify effective benefit design strategies Disseminate best practices info for insurers Provide technical assistance to high burden communities and counties* Evaluate Laws/Policies/Regulations Evaluate laws/policies/regulations implemented in states, including their impact on heroin and prescription drug abuse/overdose Disseminate information on effective laws/policies/regulations *These activities are being conducted through PFS only all other activities are conducted through both Boost and PFS. ***Through PFS, states can propose Rapid Response Projects that break new ground in any of these areas. Short (1 year) Policy/Program Development PDMPS Authority to send proactive reports Mandatory registration & use Reduced data collection interval (e.g., real time reporting) Increased use of standard PDMP reports for surveillance and other purposes Insurers/Health Systems Increase enrollment in PRR programs Implemented robust drug utilization review programs Implemented enhanced drug formularies Revised policy on Medication Assisted Treatment (MAT) Strengthened Evidence Evidence of effectiveness for pain clinic laws Evidence of effectiveness for clinical guidelines/rules Evidence of effectiveness for licensure boards enforcement policies and practices Evidence of effectiveness for immunity/naloxone laws State-Level Outcomes Medium (1 3 years) Behavior Change Providers Increased use of PDMPs Decreased rate of high-dose (>100 MME/day) opioid Rxs Decreased rate of dangerous drug combinations Decreased prescribing patterns inconsistent with guidelines/rules Increased # of patients on MAT Decreased use of methadone for pain Patients Decreased doctor shopping rate Reduced barriers to seeking help and responding with naloxone to an overdose Insurers/Health Systems Enhanced adoption of opioid prescribing guidelines* Increased number of patients enrolled in PRR programs Reduced number of providers and MME/day among PRR enrollees Increased use of claims reviews to identify outlier providers Oversight/Enforcement Increased law enforcement and licensure boards using PDMP data Increased enforcement actions against outlier providers Decreased number of pill mills Long (3 5 years) Health Outcomes Fewer drug diversion cases Increased opioid substance abuse treatment admissions (ultimately want decrease) Decreased rate of ED visits due to controlled prescription drugs Decreased drug overdose death rate Improvement in treatment of pain **High-Risk Prescribing/ Patient Behaviors High-dose opioids (>100 MME/day) Multiple providers Co-prescribing of opioids and benzodiazepines Lack of access to substance abuse treatment
12 Move toward universal PDMP registration and use Make PDMPs easier to use and access Move toward a real-time PDMP Expand and improve proactive reporting Conduct public health surveillance with PDMP 1 2 Enhance and Maximize PDMPs Community or Health System Interventions Implement or improve opioid prescribing interventions for insurers, health systems, or pharmacy benefit managers. This includes: Prior authorization, prescribing rules, academic detailing, CCPs, PRRs, Enhance adoption of opioid prescribing guidelines Prevention for States Program COMPONENTS Rapid Response Projects State Policy Evaluation Allow states to move on quick, flexible projects to respond to changing circumstances on the ground and move fast to capitalize on new prevention opportunities. 4 3 Build evidence base for policy prevention strategies that work like pain clinic laws and regulations, or naloxone access laws
13 Opioid Prescribing Guidelines for Chronic Pain Outside of Active Cancer, Palliative, & End-of-life Care PRIMARY CARE
14 Leveraging AHRQ Systematic Review Sept 2014
15 Process Used to Develop the Guidelines GRADE Method Multi-staged development with stakeholder input Projected release in 2016
16 Clinical Practices Opioid Prescribing Addressed in the Guidelines Determining when to initiate or continue opioids for chronic pain Intended for primary care providers. Opioid selection, dosage, duration, follow-up, and discontinuation Will apply to patients >18 years old in chronic pain outside of end-of-life care Assessing risk and addressing harms of opioid use
17 For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA Telephone: CDC-INFO ( )/TTY: Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Special thanks to Noah Aleshire for his assistance preparing this presentation
CDC s Prevention Efforts to Address Prescription Opioid Epidemic
CDC s Prevention Efforts to Address Prescription Opioid Epidemic Jan Losby, PhD, MSW Lead, Prescription Drug Overdose Health Systems and State Support Team Division of Unintentional Injury Prevention NASBO
More informationPopulations at risk for opioid overdose
Populations at risk for opioid overdose Len Paulozzi, MD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention April
More informationPRESCRIPTION PAINKILLER OVERDOSES
IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky
More informationPrescription Drug Abuse and Overdose: Public Health Perspective
Prescription Drug Abuse and Overdose: Public Health Perspective [Residency educators may use the following slides for their own teaching purposes.] CDC s Primary Care and Public Health Initiative October
More informationData-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014
Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014 Denise Paone and Alexandra Harocopos Bureau of Alcohol & Drug Use Prevention, Care & Treatment New York City Department
More informationPrescription Opioid Overdose & Misuse in Oregon
Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon In-State Policy Workshop NGA Policy Academy: Reducing
More information2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
More informationPresentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP
More informationMassachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
More informationMaximizing Use of Prescription Drug Monitoring Programs
Maximizing Use of Prescription Drug Monitoring Programs Christopher M..Jones, PharmD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease
More informationPrescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010
Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence Service Officer Tennessee Department of
More informationFederal Response to Opioid Abuse Epidemic
Healthcare Committee Federal Response to Opioid Abuse Epidemic On May 1, 20215 the Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled What is the Federal Government
More informationPrescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices
Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices National Governors Association Policy Academy: Reducing Prescription Drug Abuse June 8, 2015 Burlington, VT Improving Interstate
More informationDrug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008
PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease
More informationFor a Healthier America: Reducing Prescription Drug Misuse and Abuse
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
More informationJane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture
Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational
More informationStrong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER
Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER November 17, 2015 Today s Speakers Karmen Hanson, Program Manager, NCSL Cynthia Reilly, Director,
More informationPrescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013
Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi Signe Shackelford, MPH Policy Analyst November 19, 2013 Center for Mississippi Health Policy Independent, non-profit organization
More informationPrescription Drug Monitoring Programs
Prescription Drug Monitoring Programs Montana State Fund 13 th Annual Medical Conference November 1, 2013 Peter Kreiner, Ph.D. PDMP Center of Excellence at Brandeis University Primary non-heroin opiates/synthetics
More informationNorthwest Primary Care Practitioners Presentation Tackling the Opioid Epidemic in Oregon
Northwest Primary Care Practitioners Presentation Tackling the Opioid Epidemic in Oregon Dwight Holton Chief Executive Officer Lines for Life 971-244-1370 DwightH@linesforlife.orrg Page 1 of 21 14 Masters
More informationSTATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that
More informationOpioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
More informationThe Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community
The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community November 2014 INTRODUCTION The Heroin
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN)
Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management. The Centers
More informationOVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E
OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E Sales of opioids: Michigan is above the median in
More informationArkansas Emergency Department Opioid Prescribing Guidelines
Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular
More informationKing County Drug Trends 2015
Brad Finegood, MA, LMHC Assistant Division Director, Acting RSN Administrator Prevention and Treatment Coordinator King County Behavioral Health and Recovery Division Caleb Banta-Green PhD, MPH, MSW Senior
More informationOpioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA
Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA American Academy of Hospice and Palliative Care Medicine October,
More informationA Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death
A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death 2013 WPHA-WALHDAB Annual Conference Wednesday, May 22: 2:00-2:35 pm Lisa Bullard-Cawthorne, MS, MPH OPIATE PREVALENCE IN DANE
More informationSubstance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
More informationReforming the Response To Substance Use: A Drug Policy for the 21 st Century
Reforming the Response To Substance Use: A Drug Policy for the 21 st Century 2015 NASADAD MEETING Charleston, SC June 2, 2015 David Mineta, Deputy Director Office of Demand Reduction Office of National
More informationThe Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section
The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who
More informationDrug Testing to Support Pain Management
NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of
More informationPrescription Drug Monitoring Programs: Evaluation of Effectiveness
Prescription Drug Monitoring Programs: Evaluation of Effectiveness Eric Lavonas, MD Associate Director, Rocky Mountain Poison and Drug Center Denver Health and Hospital Authority Associate Professor, Department
More informationTraci C. Green, PhD, MSc Jody Rich, MD, MPH
Traci C. Green, PhD, MSc Jody Rich, MD, MPH Strategic Plan highlights Comments & Responses from public, stakeholders Input and discussion Next steps Death rate for U.S. non-hispanic whites (USW), U.S.
More informationMayor s Task Force On Prescription Painkiller Abuse
Mayor s Task Force On Prescription Painkiller Abuse Interim Report January 2013 BACKGROUND In response to a growing epidemic, in late 2011 Mayor Bloomberg created the multi-agency Task Force on Prescription
More informationPennsylvania s ABC-MAP Program
Pennsylvania s ABC-MAP Program Recommendations on Best Practices ABC-MAP Governance Board Meeting May 20, 2015 Brandon C. Maughan, MD, MHS Marcus A. Bachhuber, MD University of Pennsylvania Philadelphia
More informationNaloxone Distribution for Opioid Overdose Prevention
Naloxone Distribution for Opioid Overdose Prevention Caleb Banta-Green PhD, MPH, MSW Alcohol and Drug Abuse Institute, University of Washington Alan Melnick, MD, MPH Clark County Public Health Chris Humberson,
More informationPrescriber Behavior, Pain Treatment and Addiction Treatment
Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy
More informationGovernor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu
Governor s Task Force on Mental Health and Substance Use www.ncdhhs.gov/mhsu Problem Statement 97 Painkiller prescriptions per 100 North Carolinians Number of deaths by drug overdose in North Carolina
More informationThe Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE
The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion Angela Huskey, PharmD, CPE Case Bill is a 47 year old man with a history of low back pain and spinal stenosis Not a real
More informationMandating PDMP participation by medical providers: current status and experience in selected states
Prescription Drug Monitoring Program Center of Excellence at Brandeis COE Briefing Mandating PDMP participation by medical providers: current status and experience in selected states Revision 1, February
More informationTestimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition
Testimony on Opioid Overdose Prevention Daniel Raymond, Policy Director, Harm Reduction Coalition Presented on March 25, 2014 to the House Appropriations Subcommittee on Labor, Health and Human Services,
More informationThe Post SB 437 Landscape: Changes in Drug Abuse Patterns in West Virginia 2012 to 2014. Emerging Public Health Challenges? Jim Kaplan MD OCME - WV
The Post Landscape: Changes in Drug Abuse Patterns in West Virginia 212 to 214 Emerging Public Health Challenges? Jim Kaplan MD OCME - WV Passed March 1, 212; effective June 8 Defines Chronic Pain DHHR
More information3/27/2012. Supply and Demand: The Substance Abuse/Misuse Market Triangle
Substance Abuse and Misuse: A Tragic Market That Can Be Curtailed Tennessee Department of Health Protect, promote, and improve the health and prosperity of persons in the State of Tennessee. John J. Dreyzehner,
More informationLazarus Recovery Services
Lazarus Recovery Services Overdose Survivors Group Family Addiction Support Family Peer Specialist Support Housing Family Overdose Support Biological Psychological Parent/ Family Empowerment Faith Individual
More informationA Multi-Systemic Approach for Reducing Health and Criminal Justice Consequences Pinal County Year 1 Progress
The Arizona Prescription Drug Misuse and Abuse Initiative A Multi-Systemic Approach for Reducing Health and Criminal Justice Consequences Pinal County Year 1 Progress Evaluation: Conceptual Framework Expected
More informationUNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,
More information2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California
2015 OPSC Annual Convention syllabus February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California FRIDAY, FEBRUARY 6, 2015: 9:30am - 10:30am Opioid Addiction and Buprenorphine Use * Presented by
More informationA Healthesystems Clinical Analysis. Insidious Incrementalism of Opioid Use in Workers Compensation
A Healthesystems Clinical Analysis Insidious Incrementalism of Opioid Use in Workers Compensation Prescription opioid use in the United States has grown significantly over the past 20 years. In 1991, there
More informationTestimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,
More informationInventory Management Tracking, Distribution and Delivery
Inventory Management Tracking, Distribution and Delivery Ben Erickson Public Health Analyst Office of Public Health Preparedness and Response Division of Strategic National Stockpile Agenda Inventory Management
More informationThe ABCs of Medication Assisted Treatment
The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment
More informationTrends of Opioid Misuse and Diversion: Lessons from the United States
Trends of Opioid Misuse and Diversion: Lessons from the United States 31 October 2012 Richard C. Dart, MD, PhD Director Rocky Mountain Poison and Drug Center Professor - University of Colorado, Department
More informationKing County, WA Drug Trends Through June 2014 Treatment and Mortality Caleb Banta-Green PhD MPH MSW Senior Research Scientist- Alcohol and Drug Abuse
King County, WA Drug Trends Through June 2014 Treatment and Mortality Caleb Banta-Green PhD MPH MSW Senior Research Scientist- Alcohol and Drug Abuse Institute Affiliate Associate Professor- School of
More informationColorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy
Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace
More informationSecond Annual Florida 2008 Electronic Prescribing Report
Second Annual Florida 2008 Electronic Prescribing Report FLORIDA CENTER FOR HEALTH INFORMATION AND POLICY ANALYSIS AGENCY FOR HEALTH CARE ADMINISTRATION JANUARY 2009 Better Health Care for All Floridians
More informationTestimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment
Testimony of Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment New York City Department of Health and Mental Hygiene before the New York City
More informationA Review of the Impacts of Opiate Use in Ontario: Summary Report
A Review of the Impacts of Opiate Use in Ontario: Summary Report A Provincial Summary Report of the Impacts of the Discontinuation of Oxycontin in Ontario: January to August 2013 December 2013 This report
More informationPrescription Drug Abuse in the US
TM The other epidemic: Prescription Drug Abuse in the US Ten prevention ideas from the states Len Paulozzi, MD, MPH National Center for Injury Prevention and Control Presented at the National Conference
More informationSummit Spotlight Treatment Track breakout sessions announced
Volume 5, Issue 15, December 21, 2015 In This Issue: * Treatment Track breakout sessions announced 1. Drug overdose deaths reach all- time high 2. CDC releases draft opioid guidelines; seeks comments 3.
More informationWhat is an opioid? Why address opioid use in your county? Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose
Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose What is an opioid? Opioids are a type of pain-relief medication. According to the National Institute on Drug
More informationWashington State Interagency Opioid Working Plan
Washington State Interagency Opioid Working Plan INTRODUCTION January 2016 Washington State is currently experiencing an opioid abuse and overdose crisis involving prescription opioids and heroin. Approximately
More informationThe Prescription Drug Abuse and Heroin Crisis: New York s Response
The Prescription Drug Abuse and Heroin Crisis: New York s Response Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 The Connection States with more opioid
More informationPrescription Drug Abuse Florida s Health Crisis
Prescription Drug Abuse Florida s Health Crisis Overview Florida has been the epicenter for the diversion and abuse of prescription drugs. Prescription drugs killed almost 7 Floridians per day after an
More informationHow To Get A Prescription In Rhode Island
Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures
More informationAmerican Cancer Society Cancer Action Network
American Cancer Society Cancer Action Network 555 11 th Street, NW Suite 300 Washington, DC 20004 202.661.5700 www.acscan.org Tom Frieden, M.D., M.P.H. Director, Centers for Disease Control and Prevention
More informationDear Chairman Hardy, Chairman Oscarson, and Members of the Committee:
Testimony Joint Senate and Assembly Health and Human Services Committee Wednesday, April 1, 2015 3:30 p.m. SB 459 Dear Chairman Hardy, Chairman Oscarson, and Members of the Committee: My name is Linda
More informationARIZONA SUBSTANCE ABUSE PARTNERSHIP Governor s Office for Children, Youth and Families
Rx DRUG MISUSE AND ABUSE INITIATIVE IMPLEMENTATION PLAN ARIZONA SUBSTANCE ABUSE PARTNERSHIP Governor s Office for Children, Youth and Families Introduction The Arizona Rx Drug Misuse and Abuse Initiative
More informationPreventing Prescription Drug Abuse: An Important Role for State Injury Prevention Programs
Preventing Prescription Drug Abuse: An Important Role for State Injury Prevention Programs 2012 Joint tannual lmeeting of the Sf Safe States t Alliance and CDC Core Violence and Injury Prevention Program
More informationThe Arizona Prescription Drug Misuse and Abuse Initiative: A Multi-Systems Approach to Addressing Prescription Drug Misuse and Abuse
The Arizona Prescription Drug Misuse and Abuse Initiative: A Multi-Systems Approach to Addressing Prescription Drug Misuse and Abuse Presented by: Phillip Stevenson, Ph.D. Director, Statistical Analysis
More informationHeroin in Snohomish County: Mortality and Treatment Trends
Heroin in Snohomish County: Mortality and Treatment Trends January 2015 This page left intentionally blank. Table of Contents Introduction and Acknowledgments 1 Executive Summary 2 Mortality Overdose Mortality
More informationAmerican Indian Health Commission for Washington State October 1, 2015
American Indian Health Commission for Washington State October 1, 2015 States with more opioid pain reliever sales tend to have more drug overdose deaths Death rate, 2011, National Vital Statistics System.
More information2013 OHIO DRUG OVERDOSE DATA: GENERAL FINDINGS 1
Number of Deaths Rate per 100,000 persons 2013 OHIO DRUG OVERDOSE DATA: GENERAL FINDINGS 1 Drug overdose deaths continue to be a public health crisis in Ohio with a 413 percent increase in the number of
More informationStatement. of the. American Medical Association. to the
Statement of the American Medical Association to the Committee on Energy & Commerce Subcommittee on Oversight and Investigations United States House of Representatives Re: Combatting the Opioid Abuse Epidemic:
More informationMedical Malpractice Treatment Alprazolam benzodiazepine - A Case Study
Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Pik-Sai Yung, M.D. Staff Psychiatrist Center for Counseling at Walton Background and Rationale Alprazolam is
More informationAsk your doctor if taking a pill to solve all your problems is right for you.
Ask your doctor if taking a pill to solve all your problems is right for you. Statewide Workgroup on Reducing Overuse: Opioid Overuse Neal Kohatsu, MD Kelly Pfeifer, MD October 29, 2015 90 80 70 Annual
More informationProtecting your employees, physicians and you.
Protecting your employees, physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution - now with real outcomes. Opioids are the most common drugs prescribed in workers
More informationAppendix 14: Obtaining Data on Opioid Poisoning
: Obtaining Data on Opioid Poisoning Obtaining Hospital Data on Nonfatal Opioid Poisoning Data on the number of nonfatal opioid overdoses can often be obtained from hospitals serving your community. Forming
More informationVermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner. NASADAD 2015 Annual Meeting
Vermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner NASADAD 2015 Annual Meeting Background Goal of Health Care Reform Triple Aim: Better Population
More informationJAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.
THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII JAN 0 A BILL FOR AN ACT S.B. NO. % RELATING TO DRUG OVERDOSE PREVENTION BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 0 SECTION. The legislature
More informationVisit www.takebackmylife.org to hear more of my story or call 211 for help and treatment options
In high school, I experimented with alcohol and pot. Then I moved on to narcotics and cocaine, which landed me in jail several times. By 25, I was a daily heroin user with a long-term prison sentence.
More information6/19/2014. Opiate and Heroin Abuse in Rural Communities Litchfield County Opiate Task Force
Opiate and Heroin Abuse in Rural Communities Litchfield County Opiate Task Force Joy Pendola; LMFT, LADC, Clinical Manager of DDIOP and Adult Behavioral Health Services at the Charlotte Hungerford Hospital
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationConfronting the Crisis of Opioid Addiction: An Overview of Beacon s White Paper
Confronting the Crisis of Opioid Addiction: An Overview of Beacon s White Paper August 2015 Introduction Agenda Brief introduction to Beacon and our speakers Overview of Beacon s White Paper in response
More informationPrescription Drug Monitoring Programs: A State Policy to Address Prescription Opioid Poisonings. Michael Kim, MPH April 30, 2012
Prescription Drug Monitoring Programs: A State Policy to Address Prescription Opioid Poisonings Michael Kim, MPH April 30, 2012 Overview 1. Prescription Opioid Abuse and Poisoning 2. Prescription Drug
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationHow To Help People Who Are Addicted To Prescription Drugs And Heroin
Community Behavioral Healthcare Association of Illinois Frank Anselmo, MPA Chief Executive Officer 3085 Stevenson Drive, Suite 203 Springfield, Illinois 62703 Phone: 217/585-1600 Fax: 217/585-1601 www.cbha.net
More informationThe Changing Face of Opioid Addiction:
9th Annual Training and Educational Symposium September 6, 2012 The Changing Face of Opioid Addiction: A Review of the Research and Considerations for Care Mark Stanford, Ph.D. Santa Clara County Dept
More informationAn integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 Background Defining the problem: Opiates pain relievers (OxyContin,
More informationTestimony of The New York City Department of Health and Mental Hygiene. before the
Testimony of The New York City Department of Health and Mental Hygiene before the New York City State Assembly Committee on Alcoholism and Drug Abuse on Programs and Services for the Treatment of Opioid
More informationSAFE PAIN MEDICATION PRESCRIBING GUIDELINES
Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses
More informationResources for the Prevention and Treatment of Substance Use Disorders
Resources for the Prevention and Treatment of Substance Use Disorders Table of Contents Age-standardized DALYs, alcohol and drug use disorders, per 100 000 Age-standardized death rates, alcohol and drug
More informationTravis Baggett, MD, MPH Jessie M. Gaeta, MD Jennifer Brody, MD, MPH Boston Health Care for the Homeless Program
Travis Baggett, MD, MPH Jessie M. Gaeta, MD Jennifer Brody, MD, MPH Boston Health Care for the Homeless Program Substance- attributable mortality Presentation of the data Implications for our model of
More informationWHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE
Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE WHAT WE KNOW The misuse and abuse of prescription drugs has become a leading cause of harm among New Hampshire adults,
More informationBREAKING THE CYCLE. Clermont County s 2015 Response to the Opiate Epidemic
BREAKING THE CYCLE Clermont County s 2015 Response to the Opiate Epidemic SPONSORED BY: Clermont County Mental Health & Recovery Board and Clermont County Public Health Understanding the Opiate Epidemic
More informationHow To Manage Prescription Drug Costs In Workers Compensation
June 2012 Jacob Lazarovic, M.D. Chief Medical Officer, SVP Broadspire Escalating Pharmaceutical Costs in Workers Compensation: One Clinical Solution One Clinical Solution Pharmaceutical (Rx) costs have
More informationNational Perspectives in Medication Assisted Treatment
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
More informationThe Opioid Addiction Epidemic: How marketing and regulatory failure led to a public health crisis
The Opioid Addiction Epidemic: How marketing and regulatory failure led to a public health crisis Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians
More information